163 related articles for article (PubMed ID: 6321006)
1. VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer.
Evans WK; Feld R; Osoba D; Shepherd FA; Dill J; Deboer G
Cancer; 1984 Apr; 53(7):1461-6. PubMed ID: 6321006
[TBL] [Abstract][Full Text] [Related]
2. Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer.
Evans WK; Osoba D; Feld R; Shepherd FA; Bazos MJ; DeBoer G
J Clin Oncol; 1985 Jan; 3(1):65-71. PubMed ID: 2981293
[TBL] [Abstract][Full Text] [Related]
3. Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
Johnson DH; Wolff SN; Hainsworth JD; Porter LL; Grosh WW; Hande KR; Greco FA
J Clin Oncol; 1985 Feb; 3(2):170-5. PubMed ID: 2981981
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer. A Southwest Oncology Group Study.
Collins C; Higano CS; Livingston RB; Griffin BR; Keppen MD; Miller TP
Cancer Chemother Pharmacol; 1989; 24(2):128-32. PubMed ID: 2543513
[TBL] [Abstract][Full Text] [Related]
5. VP-16 and cisplatin as first-line therapy for small-cell lung cancer.
Evans WK; Shepherd FA; Feld R; Osoba D; Dang P; Deboer G
J Clin Oncol; 1985 Nov; 3(11):1471-7. PubMed ID: 2997406
[TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer.
Shepherd FA; Evans WK; MacCormick R; Feld R; Yau JC
Cancer Treat Rep; 1987 Oct; 71(10):941-4. PubMed ID: 2820571
[TBL] [Abstract][Full Text] [Related]
7. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
[TBL] [Abstract][Full Text] [Related]
8. First-line therapy with VP-16 and cisplatin for small-cell lung cancer.
Evans WK; Shepherd FA; Feld R; Osoba D; DeBoer G
Semin Oncol; 1986 Sep; 13(3 Suppl 3):17-23. PubMed ID: 3020694
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
[TBL] [Abstract][Full Text] [Related]
10. The use of VP-16 plus cisplatin during induction chemotherapy for small-cell lung cancer.
Evans WK; Feld R; Murray N; Pater J; Shelley W; Willan A; Osoba D; Levitt M; Coy P; Hodson I
Semin Oncol; 1986 Sep; 13(3 Suppl 3):10-6. PubMed ID: 3020692
[TBL] [Abstract][Full Text] [Related]
11. Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study.
McCracken JD; Janaki LM; Crowley JJ; Taylor SA; Giri PG; Weiss GB; Gordon W; Baker LH; Mansouri A; Kuebler JP
J Clin Oncol; 1990 May; 8(5):892-8. PubMed ID: 2159055
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy in small cell lung carcinoma. A randomized study of two intensive regimens.
Lowenbraun S; Birch R; Buchanan R; Krauss S; Durant J; Perez C; Mill W; Vollmer R; Ogden L
Cancer; 1984 Dec; 54(11):2344-50. PubMed ID: 6093979
[TBL] [Abstract][Full Text] [Related]
13. High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancer.
Johnson DH; DeLeo MJ; Hande KR; Wolff SN; Hainsworth JD; Greco FA
J Clin Oncol; 1987 May; 5(5):703-9. PubMed ID: 3033161
[TBL] [Abstract][Full Text] [Related]
14. [Adriamycin, cisplatin, and etoposide combination chemotherapy for small cell lung cancer].
Irino S; Fujita J; Yamaji Y; Futami H; Hashimoto Y; Bungo M; Iuchi Y; Kamei M; Nakamura H; Hata Y
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2263-7. PubMed ID: 2544150
[TBL] [Abstract][Full Text] [Related]
15. Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.
Ihde DC; Mulshine JL; Kramer BS; Steinberg SM; Linnoila RI; Gazdar AF; Edison M; Phelps RM; Lesar M; Phares JC
J Clin Oncol; 1994 Oct; 12(10):2022-34. PubMed ID: 7931470
[TBL] [Abstract][Full Text] [Related]
16. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
[TBL] [Abstract][Full Text] [Related]
17. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
Johnson BE; Bridges JD; Sobczeck M; Gray J; Linnoila RI; Gazdar AF; Hankins L; Steinberg SM; Edison M; Frame JN; Pass H; Nesbitt J; Holden D; Mulshine JL; Glatstein E; Ihde DC
J Clin Oncol; 1996 Mar; 14(3):806-13. PubMed ID: 8622028
[TBL] [Abstract][Full Text] [Related]
18. [Cisplatin, adriamycin and VP-16 (CAV) in the treatment of small cell carcinoma of the lung].
Yokoyama A; Kinameri K; Kurita Y
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2573-8. PubMed ID: 6095762
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer.
Einhorn LH; Crawford J; Birch R; Omura G; Johnson DH; Greco FA
J Clin Oncol; 1988 Mar; 6(3):451-6. PubMed ID: 2832549
[TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]